Navigation Links
Zimmer Holdings, Inc. Reports First Quarter 2013 Financial Results
Date:4/25/2013

#160;Basic 

168.7177.4Diluted 

170.7178.5 Cash dividends declared per common share 

$
.20$
-  ZIMMER HOLDINGS, INC.  CONDENSED CONSOLIDATED BALANCE SHEETS  (in millions, unaudited)  March 31,  December 31, 20132012 Assets  Current Assets: Cash and cash equivalents $
57.0

$
884.3Short-term investments 544.2

671.6Receivables, net 912.5

884.6Inventories 1,039.1

995.3Other current assets 311.2

272.9Total current assets 3,464.0

3,708.7 Property, plant and equipment, net 1,219.5

1,210.7 Goodwill 2,534.8

2,571.8 Intangible assets, net 722.7

740.7 Other assets 803.6

780.5 Total Assets $
8,744.6

$
9,012.4
 Liabilities and Stockholders' Equity  Current liabilities $
763.3

$
765.9 Short-term debt -

100.1 Other long-term liabilities 566.1

559.3 Long-term debt 1,702.8

1,720.8 Stockholders' equity 5,712.4

5,866.3 Total Liabilities and Stockholders' Equity $
8,744.6

$
9,012.4
  ZIMMER HOLDINGS, INC.  CONSOLIDATED STATEMENTS OF CASH FLOWS  FOR THE THREE MONTHS ENDED MARCH 31, 2013 and 2012  (in millions, unaudited) 20132012 Cash flows provided by (used in) operating activities  Net earnings $
218.0

$
208.9 Depreciation and amortization 85.1

96.8 Sha
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
2. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
3. UPDATE: Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
4. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
5. Zimmer Holdings to Present at Canaccord Genuitys Musculoskeletal Conference
6. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
7. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
8. Zimmer Reports Fourth Quarter and 2012 Financial Results
9. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
10. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
11. Zimmer Holdings to Present at 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Moerae Matrix, a clinical stage biotechnology ... inflammation and fibrosis, today announced the appointment of ... Medical Officer. Dr. Bradford will ... which include a pipeline of therapies for pulmonary ... is an accomplished strategist and scientist with extensive ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... --  Cepheid (Nasdaq: CPHD ) today announced that ... quarter ended June 30, 2015 on Thursday, July 23, ... The Company will host a management presentation at 2 ... discuss the results.  To access the live webcast, please ... 15 minutes before the scheduled start time to download ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... 2011 VolitionRX Limited ("Volition") (VNRX.OB), ... diagnostic tests, is pleased to announce that its ... signed a contract which is expected to provide ... commissioned to develop epigenetic profiling signatures from blood. ...
... Technology Services successfully implemented advanced process technology for ... in Shanghai, China, using Intergraph® integrated design and ... solvent and energy consumption as well as operating ... http://photos.prnewswire.com/prnh/20081211/DECLOGO) These results are achieved, among ...
Cached Medicine Technology:VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures 2VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures 3Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 2Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China 3
(Date:7/6/2015)... Rancho Cucamonga, Ca (PRWEB) , ... July 06, 2015 , ... ... two distinguished awards in 2015, marking him as an attorney who has ... Fernando Vargas received both a Client Distinction Award for 2015 from Martindale-Hubbell and a ...
(Date:7/6/2015)... ... , ... University of Pittsburgh Cancer Institute (UPCI) scientists recently led ... newly available tests that better incorporate personalized medicine into diagnosing the condition. , ... is published in the July issue of the scientific journal Thyroid . ...
(Date:7/6/2015)... ... July 06, 2015 , ... Shortly after opening her ... the leading network of doctors working on a lien basis. Dr. Lim had ... , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain herself ...
(Date:7/6/2015)... Virginia (PRWEB) , ... July 06, 2015 , ... ... choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction regularly ... For a particular demographic, however, fat reduction has become more than a way ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... for radiology services and ADVOCATE is leading the transition. ADVOCATE, the only 100% ... with their Top 10 Tips for ICD-10. The ten tips are timely and ...
Breaking Medicine News(10 mins):Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2
... for Everyone , Not all patients can tolerate ... can help physicians calculate the epirubicin dose associated with ... , Oncologists frequently use anthracyclines, including epirubicin and doxorubicin, ... lasting heart problems in a substantial number of patients. ...
... 6.9 percent sequentially - Q2 GAAP net profit ... - Case shipments of 54,870 increase 6.0 percent sequentially ... SANTA CLARA, Calif., July 29 Align,Technology, Inc. (Nasdaq: ALGN ... ended June 30, 2008., Total net revenues for the second ...
... projected ... ... of,high-quality ceramic solutions for the medical device industry, announced,today that, in ... on unit shipments to the orthopaedic,brachytherapy and electro-implantable market segments., ...
... FACP, FACEP (E), Executive,Director, American Public Health Association, ... Association strongly urges U.S. House members to vote ... Food and Drug Administration (FDA),the authority to regulate ... for more than 400,000 deaths each,year and costs ...
... of matted protein, researchers say , , TUESDAY, July 29 (HealthDay ... clogging "tangles" in the brain cells of people with Alzheimer,s ... studies are necessary to confirm whether the medication is as ... needs to be given as part of a cocktail of ...
... ... Future Costs Can Be Avoided with Proper Treatment and Prevention ... Initiatives, NEW BRUNSWICK, N.J., ... on New,Jersey,s economy of the most common chronic diseases is calculated to be,$39 billion. In ...
Cached Medicine News:Health News:Also in the July 29 JNCI 2Health News:Also in the July 29 JNCI 3Health News:Also in the July 29 JNCI 4Health News:Also in the July 29 JNCI 5Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 2Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 3Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 4Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 5Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 6Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 7Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 8Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 9Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 10Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 11Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 12Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 13Health News:C5 Medical Werks Reaches Million Mark in Components Shipped 2Health News:'De-Tangling' Alzheimer's Drug Shows Promise 2Health News:'De-Tangling' Alzheimer's Drug Shows Promise 3Health News:'De-Tangling' Alzheimer's Drug Shows Promise 4Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 2Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 3Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 4
Inquire...
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
The computer-optimized optical design produces large, brilliant images of high resolution....
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: